探索一种来自玉米的食纤维-酸复合物,具有益生菌效应
Yujing Sun1, Gaoke Li2, Wu Li2
1State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu 214122, PR China.
Food chemistry
|July 20, 2024
概括
玉米衍生纤维-酸复合体表现出各种功能性质. CWDFPC2 显示出较高的结合化合物含量和益生菌潜力,产生更多的短链脂肪酸.
科学领域:
- 食品科学与技术 食品科学与技术
- 营养生物化学 营养生物化学
- 农业化学 农业化学
背景情况:
- 食纤维和化合物对人类健康至关重要.
- 玉米细胞壁的食纤维-酸复合物 (CWDFPCs) 是生物活性化合物的潜在来源.
- 了解这些复合物的结构和功能性质对于它们的应用至关重要.
研究的目的:
- 研究三种玉米衍生细胞壁食纤维-酸复合体 (CWDFPC1,CWDFPC2和CWDFPC3) 的结构,功能和益生菌性质.
- 为了比较不同CWDFPC的植物化学特征,抗氧化活性,水容量和体外发酵结果.
主要方法:
- 近距离构成和X射线衍射 (XRD) 模式的表征.
- 结合化合物 (BPC) 的量化和体外抗氧化活性的评估 (DPPH和ABTS测定).
- 评估水容量,酸盐离子吸附能力,胆汁吸附能力和阴离子交换能力.
- 在体外便发酵48小时以测量短链脂肪酸 (SCFA) 生产.
主要成果:
- 所有CWDFPC都表现出类似的近距离组成和XRD模式 (I型).
- 在化合物概况中观察到显著的差异,CWDFPC2具有最高的BPC含量 (15.41 mg GAE/g) 和优越的抗氧化活性.
- CWDFPC1和CWDFPC3显示出比CWDFPC2更高的水容量,而酸盐离子吸附,胆汁吸附和阴离子交换能力在三者之间都是相似的.
- 与CWDFPC1 (40.26 mM) 和CWDFPC3 (44.20 mM) 相比,CWDFPC2在体外发酵后产生了更多的SCFA (46.33 mM).
结论:
- 玉米衍生CWDFPC具有独特的结构和功能特征,受其化合物配置的影响.
- CWDFPC2因其较高的结合含量,抗氧化能力和益生菌潜力而脱而出,由增加的SCFA生产表明.
- 这些发现凸显了特定CWDFPC作为具有多种健康益处的功能成分的潜力.
更多相关视频
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
3.9K
10:30A Generalized Method for Determining Free Soluble Phenolic Acid Composition and Antioxidant Capacity of Cereals and Legumes
Published on: June 10, 2022
6.8K
相关概念视频
Cellulose and Pectic Polysaccharides
3.5K
Every plant cell has a cell wall that protects the cell, provides structural support, and gives the cell shape. Cellulose, the main structural component of the plant cell wall, makes up over 30% of plant matter. It is the most abundant organic compound on earth. Cellulose is an unbranched polysaccharide composed of linear chains of glucose molecules linked by β (1→4) glycosidic bonds.
As a cell matures, its cell wall specializes according to its type. For example, the...
As a cell matures, its cell wall specializes according to its type. For example, the...
3.5K
Drugs for Treatment of Constipation-Predominant IBS
152
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
152
